0

539680

GANGAPHARM

img img img img
No Data Available

Ganga Pharmaceuticals Limited Share Price Update

As of the latest trading session, Ganga Pharmaceuticals Limited is trading at ₹12, up by ₹0.00 or 0.00% from its previous close. The stock has moved between ₹12.00 and ₹12.00 today. Over the past year, the stock has delivered a return of -12.08%. In the last month, it has returned 1.69%.

Investment Returns

Over 1 Month 1.69% Over 3 Months 2.73% Over 6 Months -17.80% Over 1 Year -12.08%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Ganga Pharmaceuticals Limited fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 0.0
  • P/E Ratio (TTM) 0.0
  • Beta 0.0
  • Book Value / share 0.0
  • Return on equity 0.0%
  • EPS (TTM) 0.0
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 0.0
info icon alternate text

Ganga Pharmaceuticals Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars JUN 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.00
Net Profit 0.00
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.00
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 2.64
Operating Expense 2.98
Net Profit 0.08
Net Profit Margin (%) 3.03
Earnings Per Share (EPS) 0.16
EBITDA 0.32
Effective Tax Rate (%) 22.22
Particulars MAR 2024 (Values in Cr)
Revenue 2.74
Operating Expense 2.91
Net Profit 0.05
Net Profit Margin (%) 1.82
Earnings Per Share (EPS) 0.11
EBITDA 0.29
Effective Tax Rate (%) 33.33
Particulars MAR 2023 (Values in Cr)
Revenue 2.59
Operating Expense 2.83
Net Profit 0.04
Net Profit Margin (%) 1.54
Earnings Per Share (EPS) 0.10
EBITDA 0.30
Effective Tax Rate (%) 20.00
Particulars MAR 2022 (Values in Cr)
Revenue 2.49
Operating Expense 2.69
Net Profit 0.04
Net Profit Margin (%) 1.60
Earnings Per Share (EPS) 0.09
EBITDA 0.29
Effective Tax Rate (%) 20.00
Particulars MAR 2021 (Values in Cr)
Revenue 2.37
Operating Expense 2.59
Net Profit 0.02
Net Profit Margin (%) 0.84
Earnings Per Share (EPS) 0.05
EBITDA 0.28
Effective Tax Rate (%) 50.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 13.46
ROE % 1.13
ROCE % 3.30
Total Debt to Total Equity 0.20
EBITDA Margin 12.12
Particulars MAR 2024 (Values in Cr)
Book Value / Share 13.30
ROE % 0.80
ROCE % 3.18
Total Debt to Total Equity 0.25
EBITDA Margin 10.58
Particulars MAR 2023 (Values in Cr)
Book Value / Share 13.42
ROE % 0.74
ROCE % 3.28
Total Debt to Total Equity 0.35
EBITDA Margin 11.58
Particulars MAR 2022 (Values in Cr)
Book Value / Share 13.32
ROE % 0.74
ROCE % 3.32
Total Debt to Total Equity 0.34
EBITDA Margin 12.05
Particulars MAR 2021 (Values in Cr)
Book Value / Share 13.23
ROE % 0.37
ROCE % 3.30
Total Debt to Total Equity 0.30
EBITDA Margin 11.81
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.30
Total Assets 8.97
Total Liabilities 8.97
Total Equity 7.13
Share Outstanding 0
Price to Book Ratio 0.76
Return on Assets (%) 0.88
Return on Capital (%) 0.92
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 8.64
Total Liabilities 8.64
Total Equity 7.05
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 0.53
Return on Capital (%) 0.55
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 7.98
Total Liabilities 7.98
Total Equity 5.45
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 0.49
Return on Capital (%) 0.54
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 7.99
Total Liabilities 7.99
Total Equity 5.41
Share Outstanding 0
Price to Book Ratio 0.77
Return on Assets (%) 0.47
Return on Capital (%) 0.52
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 7.66
Total Liabilities 7.66
Total Equity 5.37
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 0.26
Return on Capital (%) 0.29
Particulars MAR 2025 (Values in Cr)
Net Income 0.09
Cash from Operations -0.56
Cash from Investing 1.18
Cash from Financing -0.33
Net change in Cash 0.27
Free Cash Flow -0.46
Particulars MAR 2024 (Values in Cr)
Net Income 0.06
Cash from Operations -1.24
Cash from Investing 0.12
Cash from Financing 1.13
Net change in Cash 0.00
Free Cash Flow -1.22
Particulars MAR 2023 (Values in Cr)
Net Income 0.05
Cash from Operations -0.02
Cash from Investing 0.49
Cash from Financing -0.44
Net change in Cash 0.00
Free Cash Flow 0.00
Particulars MAR 2022 (Values in Cr)
Net Income 0.05
Cash from Operations -0.19
Cash from Investing 0.18
Cash from Financing 0.02
Net change in Cash 0.00
Free Cash Flow -0.18
Particulars MAR 2021 (Values in Cr)
Net Income 0.03
Cash from Operations -0.16
Cash from Investing 0.27
Cash from Financing -0.09
Net change in Cash 0.00
Free Cash Flow -0.14
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.33 13.56 1.62 240.09 23.12 40.44
BLISS GVS PHARMA LTD. 269.70 25.78 2.51 2853.13 105.05 280.20
CIPLA LTD. 1333.55 22.66 3.27 107721.85 1165.55 1672.20
FERMENTA BIOTECH LIMITED 298.60 9.93 2.24 878.81 252.15 399.00
GLAXOSMITHKLINE PHARMA LT 2362.25 39.79 23.43 40017.94 2218.00 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.33 30.13 4.36 240.09 23.12 40.44
AMRUTAJAN HEALTH LTD 533.50 26.68 4.50 1542.38 490.00 789.95
ASTRAZENECA PHARMA IND LT 8233.50 98.95 25.76 20583.75 7630.00 10653.05
BLISS GVS PHARMA LTD. 269.70 36.74 2.58 2853.13 105.05 280.20

Ganga Pharmaceuticals Limited shareholding pattern

Holding
49.08%
50.91%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Ganga Pharmaceuticals Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
12.00 0.00 redarrow
red-green-graph indicator
0 Bearish
0 Bullish
  • 5 Days 0.00
  • 26 Days 0.00
  • 10 Days 0.00
  • 50 Days 0.00
  • 12 Days 0.00
  • 100 Days 0.00
  • 20 Days 0.00
  • 200 Days 0.00
12.00 PIVOT
First Support 12.00 First Resistance 12.00 Second Support 12.00 Second Resistance 12.00 Third Support 12.00 Third Resistance 12.00
RSI 58.88 ADX 40.26 MACD 0.00 Williams % R -50.45 Commodity Channel Index (CCI) -18.58
Date 2026-02-12 Week 8000.00 Same Day 8000.00 Month 12000.00
1 Year -1.43 3 Year 2.71
Over 1 Month
1.69% down
Over 1 Year
-12.08% down
Over 3 Months
2.73% down
Over 3 Years
-2.63% down
Over 6 Months
-17.80% down
Over 5 Years
14.86% down

Ganga Pharmaceuticals Limited Corporate Actions

Top Gainers

Top Losers

Ganga Pharmaceuticals Limited Share Price

Ganga Pharmaceuticals Limited was incorporated as a Public Limited Company in Aug.'94 and promoted by Brij Mohan Sharma. The Company is engaged in the business of manufacturing & trading in Pharmaceuticals & allied products (Ayurveda).

In Apr.'95, the company took over Ganga pharmaceuticals, a proprietary concern (owned by the same promoter), which was manufacturing and marketing ayurvedic products since the last two decades.

The company which manufactures ayurvedic medicines, started commercial production in Apr.'95. In Jul.'96, it came out with a public issue to part-finance the expansion programme involving setting up of a new manufacturing unit for the manufacture of ayurvedic medicines at Murbad, Maharashtra.

The company which commenced exports in Jan.'96, has marketing arrangements with parties located in Saudi Arabia, Dubai, Italy, Romania and Russia to market its products in their respective regions.

Ganga's core philosophy is rooted in Ayurveda having been associated with this traditional system of healthcare for more than a decade. Ganga has been developing and successfully introducing products based on Ayurveda to cater to the ever-changing needs of the consumer. The Company has introduced new products, enhanced its distribution network and have spread awareness about the high quality of products and the the benefits that they offered.

Parent organization Indian Private
NSE symbol [-]
Founded 1989
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Ganga Pharmaceuticals Ltd?

Answer Field

Ganga Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 12.00 as on Feb 12 2026 12:00 AM.

What is the Market Cap of Ganga Pharmaceuticals Ltd Share?

Answer Field

The market cap of Ganga Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Feb 12 2026 12:00 AM.

What is the 52 Week High and Low of Ganga Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Ganga Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 14.80 and ₹ 9.35.

What is 1 year return for Ganga Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been -12.08%.

What is the P/E Ratio of Ganga Pharmaceuticals Ltd Share?

Answer Field

As on Feb 12 2026 12:00 AM the price-to-earnings (PE) ratio for Ganga Pharmaceuticals Ltd share is 0.0.

What is the PB ratio of Ganga Pharmaceuticals Ltd Share?

Answer Field

As on Feb 12 2026 12:00 AM, the price-to-book (PB) ratio for Ganga Pharmaceuticals Ltd share is 0.0.

How to Buy Ganga Pharmaceuticals Ltd Share?

Answer Field

You can trade in Ganga Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Ganga Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Ganga Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Ganga Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|